By Zachary Zagger ( April 17, 2014, 2:34 PM EDT) -- The U.S. subsidiary of Teva Pharmaceutical Industries Ltd. has struck a deal with Pfizer Inc. that will allow it to begin selling generic versions of the blockbuster arthritis drug Celebrex by the end of the year, the Israel-based generic-drug maker said Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.